EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Hypofractionated Radiotherapy Plus Temozolomide in Elderly Glioblastoma: A Systematic Review and Meta-analysis

Albert Gabriel Turpo-Peqqueña, Pierina Valeria Bermejo-Rosado, Claudia Solange Núñez-Basurco, Rayza Ruth Osorio Pacheco, Daniela Lucía Díaz Barrios, Flor Angel Brenda Zea Hinojosa, Maria Jose Bellido Gonzales, Jhoselyn Gallegos Sanabria, Fiorella Barriga Castro, Fernanda Zuñiga Morales, German Obando Rivera, Diego José Barreda Angulo und 7 weitere

ONKORESEARCH · 29.12.2025 · 3 (3) · 103-113

DOI: 10.69482/onkoresearch.v3i3.86 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift ONKORESEARCH, online erschienen am 29.12.2025. Verfasst von Albert Gabriel Turpo-Peqqueña und 18 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glioblastoma multiforme (GBM) has a poor prognosis in elderly patients, in whom standard multimodal therapy is often limited by comorbidities and treatment-related toxicity. Hypofractionated radiotherapy (HFRT) combined with temozolomide (TMZ) has been proposed as an alternative approach, but its effectiveness remains uncertain. Materials and methods: A systematic review and single-arm meta-analysis were conducted in accordance with PRISMA guidelines. PubMed, Embase, Scopus, Web of Science, and CENTRAL were searched from inception through February 2025. Prospective and retrospective studies evaluating moderate hypofractionated radiotherapy plus TMZ in patients aged ≥70 years with newly diagnosed GBM were included. Outcomes assessed were overall survival (OS), progression-free survival (PFS), radiographic tumor response, and treatment-related adverse events. Quantitative synthesis was performed using a random-effects model, and risk of bias was assessed with ROBINS-I.

Results

Nine studies were included. Median OS ranged from 5.5 to 15.8 months. The longest OS (15.8 months) was reported with 40.05 Gy in 15 fractions plus TMZ, whereas the shortest OS (5.5 months) was observed in a study using variable hypofractionated schedules (30–45 Gy in 10–15 fractions). Median PFS ranged from 4.5 to 8.5 months, with the highest value reported for 45 Gy in 15 fractions and the lowest for 40 Gy in 15 fractions. Exploratory observations suggested variability in tumor response according to baseline Karnofsky Performance Status. Hematologic toxicity was the most common adverse event. Substantial heterogeneity was observed across studies.

Conclusions

HFRT combined with TMZ may be a feasible option for selected elderly patients with GBM. However, given the heterogeneity, limited number of studies, and predominantly non-randomized designs, these findings should be interpreted as exploratory. Further well-designed prospective studies are needed.

Zitieren

APA

Turpo-Peqqueña, A. G., Bermejo-Rosado, P. V., Núñez-Basurco, C. S., Pacheco, R. R. O., Barrios, D. L. D., Hinojosa, F. A. B. Z., Gonzales, M. J. B., Sanabria, J. G., Castro, F. B., Morales, F. Z., Rivera, G. O., Angulo, D. J. B., Cervantes, D. F. M., Romero, N. D., Medina, D. N., Villanueva, L. P., Gomez, B., Huanca-Quispe, G., & Hernández-Mayori, R. (2025). Hypofractionated Radiotherapy Plus Temozolomide in Elderly Glioblastoma: A Systematic Review and Meta-analysis. ONKORESEARCH, 3(3), 103-113. https://doi.org/10.69482/onkoresearch.v3i3.86

Vancouver

Turpo-Peqqueña AG, Bermejo-Rosado PV, Núñez-Basurco CS, Pacheco RRO, Barrios DLD, Hinojosa FABZ, et al. Hypofractionated Radiotherapy Plus Temozolomide in Elderly Glioblastoma: A Systematic Review and Meta-analysis. ONKORESEARCH. 2025;3(3):103-113. doi:10.69482/onkoresearch.v3i3.86

BibTeX
@article{TurpoPeqquea2025,
  author = {Turpo-Peqqueña, Albert Gabriel and Bermejo-Rosado, Pierina Valeria and Núñez-Basurco, Claudia Solange and Pacheco, Rayza Ruth Osorio and Barrios, Daniela Lucía Díaz and Hinojosa, Flor Angel Brenda Zea and Gonzales, Maria Jose Bellido and Sanabria, Jhoselyn Gallegos and Castro, Fiorella Barriga and Morales, Fernanda Zuñiga and Rivera, German Obando and Angulo, Diego José Barreda and Cervantes, Diego Fernando Muñoz and Romero, Nicolas Daza and Medina, Diego Napoleon and Villanueva, Luis Puma and Gomez, Badhin and Huanca-Quispe, Gladys and Hernández-Mayori, Richard},
  title = {Hypofractionated Radiotherapy Plus Temozolomide in Elderly Glioblastoma: A Systematic Review and Meta-analysis},
  journal = {ONKORESEARCH},
  year = {2025},
  volume = {3},
  number = {3},
  pages = {103--113},
  doi = {10.69482/onkoresearch.v3i3.86}
}
Kostenlos starten →